Ignite Creation Date:
2025-12-24 @ 2:11 PM
Ignite Modification Date:
2026-01-22 @ 9:44 AM
Study NCT ID:
NCT00537095
Status:
COMPLETED
Last Update Posted:
2024-04-19
First Post:
2007-09-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Vandetanib (ZD6474) in Patients With Metastatic Papillary or Follicular Thyroid Cancer
Sponsor:
Genzyme, a Sanofi Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-09-28
Start Date Type:
ACTUAL
Primary Completion Date:
2009-12-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-11-24
Completion Date Type:
ACTUAL
First Submit Date:
2007-09-27
First Submit QC Date:
None
Study First Post Date:
2007-09-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-04-27
Results First Submit QC Date:
None
Results First Post Date:
2011-07-08
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-29
Last Update Post Date:
2024-04-19
Last Update Post Date Type:
ACTUAL